Skip to main content
Erschienen in: BMC Nephrology 1/2016

Open Access 01.12.2016 | Research article

Albuminuria, serum antioxidant enzyme levels and markers of hemolysis and inflammation in steady state children with sickle cell anemia

Erschienen in: BMC Nephrology | Ausgabe 1/2016

Abstract

Background

Oxidative stress is thought to be involved in the pathogenesis of microalbuminuria in Sickle cell anemia (SCA). Antioxidant enzymes such as glutathione peroxidase (GPx) and Cu-Zn superoxide dismutase (SOD) may play an important protective role. This study aimed to evaluate the association between albuminuria and these two antioxidant enzymes.

Methods

We consecutively recruited Steady state children aged between 2 and 18 years old with established diagnosis of homozygous SCA in two hospitals of Kinshasa/DR Congo. The relationship between Urinary Albumin Creatinine Ratio (UACR) and other variables of interest (age, systolic blood pressure, diastolic blood pressure, plasma GPx and Cu-Zn SOD, free plasmatic hemoglobin, LDH, indirect bilirubin, white blood cells (WBC), percentage of fetal hemoglobin, serum iron, ferritin, CRP) was analyzed by Bivariate correlation (Pearson’s correlation coefficient). Microalbuminuria was defined by urine albumin/creatinine ratio between 30 and 299 mg/g.

Results

Seventy Steady state Black African children with SCA (56% boys; average age 9.9 ± 4.3 years; 53% receiving hydroxyurea) were selected. Prevalence of microalbuminuria was 11.8%. LDH (r = 0.260; p = 0.033) and WBC count (r = 0.264; p = 0.033) were positively correlated with UACR whereas GPx (− 0.328; p = 0.007) and Cu-Zn SOD (− 0.210; p = 0.091) were negatively correlated with UACR.

Conclusions

Albuminuria is associated with decreased antioxidant capacity and increased levels of markers of hemolysis and inflammation. Therefore, strategies targeting the reduction of sickling and subsequent hemolysis, oxidative stress and inflammation could help preventing or at least delaying the progression of kidney disease in SCA children.
Abkürzungen
ARB
Angiotensin II type 1 receptor blocker
ATII
Angiotensin II
CAT
Catalase
CRP
C reactive protein
GPx
Glutathione peroxidase
HbF
Fetal hemoglobin
HU
Hydroxyurea
LDH
Lactate dehydrogenase
ROS
Reactive oxygen species
SCA
Sickle cell anemia
SOD
Super oxide dismutase
TGF β
Transforming growth factor beta
UACR
Urinary albumin creatinine ratio
WBC
White blood cell

Background

Sickle cell anemia (SCA) is a hemoglobinopathy characterized by hemolytic anemia, increased susceptibility to infections and vaso-occlusion leading to a reduced patient’s quality of life and life expectancy [1]. Oxidative stress has been reported to play a significant role in the pathophysiology of hemolysis, vaso-occlusion and subsequent organ damage including the kidneys [13]. Sickling and subsequent hemolysis and anemia increase superoxide anion and other reactive oxygen species (ROS) production and impair ROS scavenging enzymes levels and activity in SCA patients [1]. Low ROS scavenging enzymes activity, due to either low intake of vitamins or impaired synthesis of enzymes because of cofactors deficiency [4], is thought to play the main role in the pathogenesis of oxidative stress-induced vascular complications and microalbuminuria [5]. Indeed, lower activities of superoxide dismutase (SOD), glutathione peroxidase (GPx) and catalase (CAT) as well as altered levels of enzyme cofactors such as zinc, copper, selenium and iron have been reported in SCA patients without and with microalbuminuria [5]. The knowledge of the association of microalbuminuria with oxidative stress could be of therapeutic interest. Although the use of antioxidants and supplementation of enzyme cofactors can be conceivably envisaged, the prominent renoprotective effect of angiotensin II type 1 receptor blocker (ARB) Telmisartan in type 2 diabetes, a condition associated with microalbuminuria as SCA has been reported to be mediated through enhancing antioxidant defense capacity and reducing oxidative stress [6]. Unfortunately, data on oxidative stress in SCA patients with and without microalbuminuria are very scare in Africa, a setting where SCA is prevailing [710]. In order to contribute to a better understanding of the physiopathology of glomerular damage in SCA, this work aimed to study the relationship between urinary albumin creatinine ratio (UACR) and enzymatic antioxidant status assessed using two markers: serum GPx and Cu-Zn SOD, in Steady state Black African children with SCA.

Methods

Subjects and study design

The design of this cross sectional study has been described elsewhere [11]. The study was conducted over a period of three months in two hospitals of Kinshasa/DR Congo: Monkole hospital and Saint-Crispin Medical Center. We consecutively recruited Steady state children aged between 2 and 18 years old with established diagnosis of homozygous SCA by isoelectric focusing method on the Capillaris 2® (SEBIA, France) after written informed consent provided by their legal guardians. Exclusion criteria included a recent history of blood transfusion, a current crisis or history of sickle cell crisis or acute illness two months prior to the study.

Data collection procedure and laboratory analysis

For each patient, anthropometric parameters, past medical history especially current medication were obtained and physical examination performed.
A venous blood sample was collected for the determination of the level of GPx and Cu-Zn SOD as well as other biochemical parameters of interest including Fetal hemoglobin (HbF), blood count, serum creatinine, total bilirubin and its fractions, lactate dehydrogenase (LDH), iron, ferritin, C reactive protein (CRP), plasma free Hb.
Cu-Zn SOD and GPx were assayed by double-sandwich Elisa method using biotin-streptavidin system [11]. For GPx and Cu-Zn SOD, the blood samples were centrifuged for 10 min at 3000 × g and the obtained plasma was separated, aliquoted to microtubes, and stored frozen at −80 °C until testing a few days later.
Single spot morning urine specimens were collected and urine samples containing blood (1+ or greater), white blood cells (1+ or greater) and/or nitrites were excluded. Both urine dipstick test and UACR measurement were performed. UACR was performed using an immunoassay method with DCA Bayer 2000 reagent (DCA Bayer analyzer®, Siemens Healthcare Diagnostics Pyt Ltd., 885 Mountain Highway, Australia). Normal albuminuria, microalbuminuria and macroalbuminuria were defined as UACR < 30 mg/g, 30 to 299 mg/g and ≥ 300 mg/g, respectively [12].

Ethical approval

Ethical approval for the study was granted by the institutional review boards of the Monkole hospital (006 CEFA-MONKOLE/2014) in line with the principles of the Declaration of Helsinki, second revision. The aim and study procedures were explained to the parents or legal guardians and they provided written consent before any of the subjects were included.

Data management and statistical analysis

Statistical analyses were performed using SPSS (version 21.0, SPSS Inc., Chicago, USA). The primary focus in the data analysis was to assess the relationship between UACR and the antioxidant status. For this purpose, bivariate correlation (Pearson’s correlation coefficient) analyses were performed to analyze the relationships between UACR and other numerical data. Analyses were carried out with Pearson’s correlation, simple and multiple linear regressions. Step-wise multivariate regression analysis was performed to determine the independent variables for UACR. For other results, numerical variables are presented as mean ± standard deviation (SD) for normally distributed values or as median with interquartile (IQ) range for nonparametric values and categorical variables are presented as percentage. Pearson chi-square or Fisher’s exact test were used to assess differences in categorical data between groups and Student t-test or Mann Whitney U test were used to assess numerical data as appropriate. Statistical significance was defined as p value of < 0.05.

Results

General characteristics of patients

Table 1 shows the general characteristics of the study population. Seventy children with SCA in steady state (56% boys) were selected among which 68 had UACR results. Their mean age was 9.9 ± 4.3 years. Macroalbuminuria was not found in this series. Prevalence of microalbuminuria was 11.8% in the whole group. Microalbuminuria was more prevalent among girls than boys, however, there was no statistically difference between the two groups (17.2% versus 7.7%; p = 0.293.
Table 1
General characteristics of the study population
 
Whole group n = 70
Boys n = 39
Girls n = 31
p
Age, years
9.9 ± 4.4
10.5 ± 4.3
9.0 ± 4.4
0.153
Hb, g/dl
8.2 ± 1.3
7.9 ± 1.3
8.6 ± 1.4
0.040
Leukocytes, elts/mm3
11618 ± 4621
11339 ± 4114
12011 ± 5113
0.568
Platelets, elts/mm3
380727 ± 154522
364.358 ± 132.846
401.884 ± 184.553
0.344
Reticulocytes, %
12.0 (8.5–17.6)
11,0 (7,0–15,5)
14,0 (9,6–19,8)
0.117
HbF, %
8.7 (3.5–16.9)
13.9 (6.9–21.4)
6.2 (2.1–9.7)
0.004
Patients receiving HU, %
37
21
16
0.552
HbF in patients receiving HU, %
14 (7–21)
11 (6–18)
19 (13–25)
0.081
Indirect Bilirubin, mg/dl
1.9 (0.9–3.5)
1.5 (0.9–3.8)
1.9 (1.1–3.5)
0.941
Total Bilirubin, mg/dl
2.5 (1.5–4.0)
2.2 (1.3–4.3)
2.6 (1.7–4.0)
0.632
Creatinine, mg/dl
0.38 ± 1.05
0.38 ± 0.12
0.37 ± 0.11
0.600
GFR, ml/min/1.73 m2
211 ± 54
209 ± 67
215 ± 35
0.691
LDH, UI/l
544 (400–771)
457 (338–761)
653 (490–788)
0.012
CPR, mg/l
3.4 (2.0–5.1)
3.0 (1.3–4.5)
3.9 (2.8–6.9)
0.151
Iron, micromol/l
16.2 (13.2–19.2)
16.3 (14.0–21.1)
15.5 (11.5–17.8)
0.892
Ferritin, ng/ml
209 (106–453)
301 (111–613)
184 (104–378)
0.396
Free plasmatic Hb, mg/l
168 (116–267)
140 (120–240)
210 (106–288)
0.278
Cu-Zn SOD, pg/ml
305 (112–556)
281 (96–426)
360 (130–657)
0.803
GPx, micromol/l
220 (100–476)
242 (107–549)
210 (93–466)
0.699
UACR, mg/g
12 (9–22)
10 (9–20)
18 (10–26)
0.058
Values are presented as means ± SD, median (IQ 25–75) or absolute frequency
CRP C reactive protein, HU hydroxyurea, GFR glomerular filtration rate, Hb hemoglobin, HbF fetal hemoglobin, LDH lactate deshydogenase, GPx Gluthation peroxidase, SOD Superoxide dismutase, UACR Urinary albumin creatinine ratio
In the study group, 37 patients (53%) received hydroxyurea (HU). Compared with the untreated patients, those who received HU had higher rates of GPx and Cu-SOD. They also had lower levels of UACR but the difference was not statistically significant (Table 2).
Table 2
Comparison of rates of antioxidants and albuminuria based on the HU treatment
 
Treated (37)
Untreated (33)
P
GPx, micromol/l
391 (199–678)
108 (65–220)
<0.001
Cu-Zn SOD, pg/ml
402 (96–694)
132 (53–407)
0.139
UACR, mg/g
10 (9–17)
19 (10–27)
0.094
Values are presented as median (IQ 25–75)
GPx Gluthation peroxidase, SOD Superoxide dismutase, UACR Urinary albumin creatinine ratio

Correlation between UACR and study variables

Table 3 shows correlation between UACR and study variables. LDH (r = 0.260; p = 0.033) and leucocytes levels (r = 0.264; p = 0.033) were positively correlated with UACR whereas GPx (− 0.328; p = 0.007) and Cu-Zn SOD (− 0.210; p = 0.091) were negatively correlated with UACR. There was no statistically correlation between UACR and age, systolic blood pressure, diastolic blood pressure, creatinine, glomerular filtration, fetal hemoglobin, plasma free hemoglobin, serum iron, ferritin, indirect bilirubin and CRP.
Table 3
Correlation between UACR and other variables in patients studied
Variables
UACR mg/g
r
p value
GPx, micromol/l
−0.328
0.007
Cu-Zn SOD, pg/ml
−0.210
0.091
Age, years
−0.135
0.271
SBP, mmHg
0.224
0.078
DBP, mmHg
0.110
0.389
Leucocytes/mm3
0.264
0.033
Fetal Hb, %
−0.011
0.931
LDH, UI/l
0.260
0.033
Free plasmatic hemoglobin, mg/dl
0.139
0.264
Indirect bilirubin, mg/dl
−0.016
0.898
CRP, mg/l
−0.002
0.988
Serum iron, micromol/l
−0.009
0.940
Ferritin, ng/ml
−0.104
0.397

Linear regression considering UACR as dependent variable

The results related to the linear regression are reported in Table 4 and Figs. 1 and 2. Simple linear regression indicates that GPx, leucocytes levels and LDH respectively explain 10.8, 7.0 and 6.8% of the variation of UACR. The Cu-Zn SOD influences the variation of UACR by about 4.4% without reaching statistical significance. In multivariate analysis, only GPx and LDH were associated with UACR. After adjustment, these two factors account for 14.4% of change in UACR.
Table 4
Simple and Multiple linear Regression of UACR according to other variables of interest in patients studied
Variables
constant
ß coefficient
P value
R 2
Simple linear regression
 GPx, micromol/l
20.955
−0.012
0.007
0.108
 Cu-Zn SOD, pg/ml
19.943
−0.008
0.091
0.044
 Leucocytes/mm3
9.802
0.001
0.033
0.070
 LDH, UI/l
10.917
0.011
0.033
0.068
Multiple linear regression
14.727
  
0.144
 GPx, micromol/l
 
−0.010
0.049
 
 LDH, UI/l
 
0.010
0.046
 

Discussion

The main findings of the present cross-sectional study of Steady state SCA children can be summarized as follows. First, albuminuria was inversely correlated with antioxidant enzyme levels and positively to absolute white blood cell (WBC) count and LDH enzyme levels. Second, antioxidant enzyme glutathione peroxidase (GPx) and LDH levels emerged as the main independent multivariate determinants of albuminuria but the model explained only 14% of the variations of albuminuria. Third, patients receiving hydroxyurea appear to have improved antioxidant capacity and low UACR.
In our cohort, we found an inverse correlation between albuminuria and antioxidant enzyme GPx and Cu-Zn SOD. This observation is similar to previous reports from Nigeria [8], Egypt [9] and Qatar [5]. The decrease in antioxidant enzyme levels and activity could be explained by their susceptibility to ROS-induced oxidation [13, 14]. Reduced glutathione (GSH), a cofactor for GPx, is oxidized to glutathione disulfide (GSSG) through its reduction of free radicals and ROS and is an essential element to reduce hydrogen peroxide (H202). This finding may suggest that the overabundance of oxidative stress leads to consumption or inactivation this protective cofactor [13, 14]. Oxidative damage may alter both the structure and the function of the glomerulus due to its effects on mesangial and endothelial cells [8, 15]. Oxidative stress has been reported to oxidize angiotensinogen and convert it to angiotensin II (ATII) and to increase secondary angiotensin type 1 receptor (AT1R)-mediated generation of transforming growth factor-beta (TGFβ) in the kidney in SCA; excessive AT1R signaling causes SCA glomerulopathy [15, 16].
A Previous study reported the relationship between albuminuria and inflammation, and hemolysis [17]. This report has been confirmed by our results, albuminuria was positively correlated with leukocytes count and LDH level. These results suggest that the activation of vascular endothelial cells and the circulating blood cells represent the continual inflammation seen in SCA. Upon activation, circulating white blood cells and platelets express adhesion glycoproteins leading that will interact with endothelial cell adhesion molecules leading consequently to endothelial dysfunction [14].
The LDH is known to be a marker of hemolysis. The positive association between albuminuria and LDH suggest the central role of hemolysis as the starting point for many of the subsequent complications of SCA, including kidney damage [14, 18]. A Previous study has already reported a significant correlation between serum LDH levels and albuminuria [19]. Indeed, hemolysis through increased plasma-free hemoglobin concentrations can induce the generation of ROS by non-enzymatic (Fenton reaction) with subsequent oxidative stress, inflammation, endothelial dysfunction and tissue damage [14, 19]. However, the hemolytic origin of circulating LDH remains a matter of controversy. Indeed, Neely et al. found that the increase in serum LDL levels was not correlated with plasma-free hemoglobin level and suggested that the source of LDH is damaged tissue as this enzyme is an ubiquitous one and seen in nearly all living cells where it catalyzes the conversion of lactate to pyruvic acid [20].
In multivariate analysis, GPx and LDH levels were independent determinants of albuminuria but the model explained only 14% of the variation in albuminuria levels suggesting the non-inclusion in the model of other variables susceptible to influence this variation. Although an association between markers of oxidative stress and common secondary diseases in SCA have been reported, other factors such as diet, physical activity, and other comorbid diseases associated with SCA may interfere with the variations in albuminuria levels [14]. Some of these factors were not included in the present study and could explain the low determination coefficient of the multivariate model.
For decades, many studies worldwide have shown the benefit of HU in SCA [21, 22]. Although the difference did not reach statistical significance, patients who received HU had higher levels of Cu-Zn SOD and lower UACR. Unlike GPx in both groups (under HU patients and untreated patients) had reached statistical significance. The precise mechanism by which HU produces its varied effects is not fully elucidated. The efficacy of HU is generally attributed to its ability to boost the levels of HbF [23].
Our results should be interpreted within the limitations of the present work. First, the cross-sectional design of the study precludes the establishment of temporal relationships between study variables. Secondly, the small sample does not confer much power to statistics tests to identify additional associations between the study variables. Third, given the limited financial resources, we did not measure the cofactors of antioxidant enzymes and trace elements to better explain the alterations in enzymes levels. The assay of transferrin also was not done. However, we can mention that both ferritin (evaluated in present study) and transferrin prevent the iron to react with its immediate environment. Indeed, in healthy cells, the iron ions are chelated by transport proteins (transferrin) or storage proteins (ferritin). Fourth, in medical human literature, there are few data on reference values of each antioxidant or oxidative stress markers. It is known that, initially, the body will react in a moderate oxidative stress by overexpressing antioxidant enzymes (eg when exercise). If the stress persists and produces massively free radicals, SOD and GPx will be destroyed and its concentration drops. Paradoxically, a too high concentration of SOD can be dangerous because, in this case, it is the basis of a hydrogen peroxide overproduction (paradoxical effect of antioxidants) [24].

Conclusion

In the present study, albuminuria was associated with decreased antioxidant capacity and increased levels of markers of hemolysis and inflammation. Therefore, strategies targeting the reduction of Sickling and subsequent hemolysis and oxidative stress and inflammation could help preventing or at least delaying the progression of cardiovascular and kidney disease in SCA children.

Acknowledgements

The authors gratefully thank the staff of the laboratories of Monkole hospital, Saint-Crispin Medical Center and Kinshasa School of Public Health.

Funding

This work received no financial assistance from any funding agency in the public, commercial or non-profit sectors.

Availability of data and materials

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

Authors’ contributions

KEI wrote the first draft of the manuscript. KEI, FBL and JRM designed, acquired data, analyzed, interpreted data, drafted and revised the manuscript. MNA, PME, ESK, JBB, VMM, ALL, CVZ, FMK, YMN, YE, RN, JLG, PZA and NMN interpreted data and revised the manuscript. All authors read and approved the final manuscript.

Competing interests

The authors declare that they do not have any financial interest with the information contained in this paper.
Not applicable.
The study protocol was approved by the ethical committee of Monkole Medical Center (006 CEFA-MONKOLE/2014). The aim and study procedures were explained to the parents or legal guardians and they provided written consent before any of the subjects where included.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.
Literatur
1.
Zurück zum Zitat Nur E, Biemond BJ, Otten HM, Brandjes DP, Schnog JJ, CURAMA Study Group. Oxidative stress in sickle cell disease; pathophysiology and potential implications for disease management. Am J Hematol. 2011;86(6):484–9.CrossRefPubMed Nur E, Biemond BJ, Otten HM, Brandjes DP, Schnog JJ, CURAMA Study Group. Oxidative stress in sickle cell disease; pathophysiology and potential implications for disease management. Am J Hematol. 2011;86(6):484–9.CrossRefPubMed
2.
Zurück zum Zitat Baylis C. Nitric oxide deficiency in chronic kidney disease. Am J Physiol Renal Physiol. 2008;294:F1–9.CrossRefPubMed Baylis C. Nitric oxide deficiency in chronic kidney disease. Am J Physiol Renal Physiol. 2008;294:F1–9.CrossRefPubMed
4.
Zurück zum Zitat Parham M, Amini M, Aminorroaya A, Heidarian E. Effect of zinc supplementation on microalbuminuria in patients with type 2 diabetes: a double blind, randomized, placebo-controlled, cross-over trial. Rev Diabet Stud. 2008;5:102–9.CrossRefPubMedPubMedCentral Parham M, Amini M, Aminorroaya A, Heidarian E. Effect of zinc supplementation on microalbuminuria in patients with type 2 diabetes: a double blind, randomized, placebo-controlled, cross-over trial. Rev Diabet Stud. 2008;5:102–9.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Al-Naama LM, Hassan MK, Mehdi JK. Association of erythrocytes antioxidant enzymes and their cofactors with markers of oxidative stress in patients with sickle cell anemia. Qatar Med J. 2016;2015(2):14.CrossRefPubMedPubMedCentral Al-Naama LM, Hassan MK, Mehdi JK. Association of erythrocytes antioxidant enzymes and their cofactors with markers of oxidative stress in patients with sickle cell anemia. Qatar Med J. 2016;2015(2):14.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Fujita H, Sakamoto T, Komatsu K, Fujishima H, Morii T, Narita T, Takahashi T, Yamada Y. Reduction of circulating superoxide dismutase activity in type 2 diabetic patients with microalbuminuria and its modulation by telmisartan therapy. Hypertens Res. 2011;34(12):1302–8.CrossRefPubMed Fujita H, Sakamoto T, Komatsu K, Fujishima H, Morii T, Narita T, Takahashi T, Yamada Y. Reduction of circulating superoxide dismutase activity in type 2 diabetic patients with microalbuminuria and its modulation by telmisartan therapy. Hypertens Res. 2011;34(12):1302–8.CrossRefPubMed
7.
Zurück zum Zitat Abiodun EM, Aisha KG. The association of transfusion status with antioxidant enzymes and malondialdehyde level in Nigerians with sickle cell disease. Asian J Transfus Sci. 2014;8(1):47–50.CrossRefPubMedPubMedCentral Abiodun EM, Aisha KG. The association of transfusion status with antioxidant enzymes and malondialdehyde level in Nigerians with sickle cell disease. Asian J Transfus Sci. 2014;8(1):47–50.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Emokpae MA, Uadia PO. Association of oxidative stress markers with atherogenic index of plasma in adult sickle cell nephropathy. Anemia. 2012;2012:767501.CrossRefPubMedPubMedCentral Emokpae MA, Uadia PO. Association of oxidative stress markers with atherogenic index of plasma in adult sickle cell nephropathy. Anemia. 2012;2012:767501.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat El-Ghamrawy MK, Hanna WM, Abdel-Salam A, El-Sonbaty MM, Youness ER, Adel A. Oxidant-antioxidant status in Egyptian children with sickle cell anemia: a single center based study. J Pediatr (Rio J). 2014;90(3):286–92.CrossRef El-Ghamrawy MK, Hanna WM, Abdel-Salam A, El-Sonbaty MM, Youness ER, Adel A. Oxidant-antioxidant status in Egyptian children with sickle cell anemia: a single center based study. J Pediatr (Rio J). 2014;90(3):286–92.CrossRef
10.
Zurück zum Zitat Emokpae MA, Uadia PO, Godzama AA. Correlation of oxidative stress and inflammatory markers with the severity of sickle cell disease. J Pediatr (Rio J). 2014;90(3):286–92.CrossRef Emokpae MA, Uadia PO, Godzama AA. Correlation of oxidative stress and inflammatory markers with the severity of sickle cell disease. J Pediatr (Rio J). 2014;90(3):286–92.CrossRef
11.
Zurück zum Zitat Itokua EK, Ngiyulu R, Makulo JR, Lepira FB, Aloni M, Sadiki H, et al. GPx and Cu-Zn SOD activities in homozygous sickle cell anemia: the primary role of hydroxyurea. J Innov Res Health Sci Biotechnol. 2016;1(3):85–91. Itokua EK, Ngiyulu R, Makulo JR, Lepira FB, Aloni M, Sadiki H, et al. GPx and Cu-Zn SOD activities in homozygous sickle cell anemia: the primary role of hydroxyurea. J Innov Res Health Sci Biotechnol. 2016;1(3):85–91.
12.
Zurück zum Zitat Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO controversies conference report. Kidney Int. 2011;80:17–28.CrossRefPubMed Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO controversies conference report. Kidney Int. 2011;80:17–28.CrossRefPubMed
13.
Zurück zum Zitat Steinberg MH. Pathophysiologically based drug treatment of sickle cell disease. Trends Pharmacol Sci. 2006;27(4):204–10.CrossRefPubMed Steinberg MH. Pathophysiologically based drug treatment of sickle cell disease. Trends Pharmacol Sci. 2006;27(4):204–10.CrossRefPubMed
14.
Zurück zum Zitat Chirico EN, Pialoux V. Role of oxidative stress in the pathogenesis of sickle cell disease. IUBMB Life. 2012;64(1):72–80.CrossRefPubMed Chirico EN, Pialoux V. Role of oxidative stress in the pathogenesis of sickle cell disease. IUBMB Life. 2012;64(1):72–80.CrossRefPubMed
15.
Zurück zum Zitat Ataga KI, Derebail VK, Archer DR. The glomerulopathy of sickle cell disease. Am J Haematol. 2014;88(9):907–14.CrossRef Ataga KI, Derebail VK, Archer DR. The glomerulopathy of sickle cell disease. Am J Haematol. 2014;88(9):907–14.CrossRef
16.
Zurück zum Zitat Roy S, Konstantinidis DG, Rizvi T, Chang K, Sundaram N, Wourms M, et al. Increased Oxidative Stress In Sickle Cell Disease Activates The Renin-Angiotensin-TGF-β Pathway To Mediate Sickle Nephropathy. Blood. 2013:122(21):2211. Roy S, Konstantinidis DG, Rizvi T, Chang K, Sundaram N, Wourms M, et al. Increased Oxidative Stress In Sickle Cell Disease Activates The Renin-Angiotensin-TGF-β Pathway To Mediate Sickle Nephropathy. Blood. 2013:122(21):2211.
17.
Zurück zum Zitat Abdu A, Emokpae M, Uadia P, Kuliya-Gwarzo A. Proteinuria among adult sickle cell anemia patients in Nigeria. Ann Afr Med. 2011;10(1):34–7.CrossRefPubMed Abdu A, Emokpae M, Uadia P, Kuliya-Gwarzo A. Proteinuria among adult sickle cell anemia patients in Nigeria. Ann Afr Med. 2011;10(1):34–7.CrossRefPubMed
18.
Zurück zum Zitat Gurkan S, Scarponi KJ, Hotchkiss H. Lactate deshydrogenase as a predictor of of kidney involvement in patients with sickle cell anemia. Pediatr Nephrol. 2010;25:2123–7.CrossRefPubMed Gurkan S, Scarponi KJ, Hotchkiss H. Lactate deshydrogenase as a predictor of of kidney involvement in patients with sickle cell anemia. Pediatr Nephrol. 2010;25:2123–7.CrossRefPubMed
19.
Zurück zum Zitat Alzahri MS, Mousa SA, Almomen AM, Hasanato RM, Polimeni JM, Racz MJ. Lactate dehydrogenase as a biomarker for early renal damage in patients with sickle cell disease. Saudi J Kidney Dis Transpl. 2015;26(6):1161–8.CrossRefPubMed Alzahri MS, Mousa SA, Almomen AM, Hasanato RM, Polimeni JM, Racz MJ. Lactate dehydrogenase as a biomarker for early renal damage in patients with sickle cell disease. Saudi J Kidney Dis Transpl. 2015;26(6):1161–8.CrossRefPubMed
20.
Zurück zum Zitat Neely CL, Wajima T, Kraus AP, Diggs LW, Barreras L. Lactic acid dehydrogenase activity and plasma hemoglobin elevations in sickle cell disease. Am J Clin Pathol. 1969;52(2):167–9.CrossRefPubMed Neely CL, Wajima T, Kraus AP, Diggs LW, Barreras L. Lactic acid dehydrogenase activity and plasma hemoglobin elevations in sickle cell disease. Am J Clin Pathol. 1969;52(2):167–9.CrossRefPubMed
21.
Zurück zum Zitat Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the multicenter study of hydroxyurea in sickle cell anemia. N Engl J Med. 1995;332(20):1317–22.CrossRefPubMed Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the multicenter study of hydroxyurea in sickle cell anemia. N Engl J Med. 1995;332(20):1317–22.CrossRefPubMed
22.
Zurück zum Zitat Weatherall DJ. Hydroxycarbamide for sickle-cell anaemia in infancy. Lancet. 2011;377(9778):1628–30.CrossRefPubMed Weatherall DJ. Hydroxycarbamide for sickle-cell anaemia in infancy. Lancet. 2011;377(9778):1628–30.CrossRefPubMed
23.
Zurück zum Zitat Segal JB, Beach MC, Haywood C, Witkop C, Park H, Wilson RF, Bass EB, Lanzkron S. Review hydroxyurea for the treatment of sickle cell disease. Evid Report Technol Assess (Full Report). 2008;165:1–95. Segal JB, Beach MC, Haywood C, Witkop C, Park H, Wilson RF, Bass EB, Lanzkron S. Review hydroxyurea for the treatment of sickle cell disease. Evid Report Technol Assess (Full Report). 2008;165:1–95.
24.
Zurück zum Zitat Levine SA, Kidd PM. Antioxidant adaptation. Its role in free radical pathology. In: A. Biocurrents division, Allergy Research Group. San Leandro: Allergy Research Group; 1996. Levine SA, Kidd PM. Antioxidant adaptation. Its role in free radical pathology. In: A. Biocurrents division, Allergy Research Group. San Leandro: Allergy Research Group; 1996.
Metadaten
Titel
Albuminuria, serum antioxidant enzyme levels and markers of hemolysis and inflammation in steady state children with sickle cell anemia
Publikationsdatum
01.12.2016
Erschienen in
BMC Nephrology / Ausgabe 1/2016
Elektronische ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-016-0398-0

Weitere Artikel der Ausgabe 1/2016

BMC Nephrology 1/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.